{"id":"placebo-enteric-coated-tablet","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108130","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":null,"oneSentence":null,"_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:51.999Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of symptoms associated with irritable bowel syndrome"}]},"trialDetails":[{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":"Creutzfeldt-Jakob Disease","enrollment":246},{"nctId":"NCT05633810","phase":"PHASE3","title":"COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2022-12-21","conditions":"Diabete Type 2, Cardiovascular Diseases","enrollment":10000},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07205250","phase":"EARLY_PHASE1","title":"Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-02-20","conditions":"Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm","enrollment":224},{"nctId":"NCT07182890","phase":"PHASE4","title":"Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-09-20","conditions":"Functional Dyspepsia, Probiotics, Depression","enrollment":180},{"nctId":"NCT07187492","phase":"PHASE4","title":"Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2025-09-20","conditions":"Functional Dyspepsia, Probiotics, Depression","enrollment":180},{"nctId":"NCT06548971","phase":"PHASE3","title":"Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-07","conditions":"Acute Ischemic Stroke, Cerebral Infarction","enrollment":1184},{"nctId":"NCT06243835","phase":"PHASE1","title":"A Study to Test the Effects of Kindolor at Different Doses in Healthy Adults","status":"TERMINATED","sponsor":"Lohocla Research Corporation","startDate":"2024-04-21","conditions":"Chronic Pain","enrollment":16},{"nctId":"NCT05857163","phase":"PHASE3","title":"Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection","status":"COMPLETED","sponsor":"TenNor Therapeutics (Suzhou) Limited","startDate":"2023-05-18","conditions":"H.Pylori Infection","enrollment":700},{"nctId":"NCT05935787","phase":"PHASE3","title":"Cytoflavin in the Complex Rehabilitation of Stroke Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-06-09","conditions":"Stroke","enrollment":240},{"nctId":"NCT07047339","phase":"PHASE2, PHASE3","title":"Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-01","conditions":"Colitis, IBD (Inflammatory Bowel Disease), Probiotic Intervention","enrollment":120},{"nctId":"NCT06935994","phase":"PHASE2","title":"Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","status":"RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2025-05-05","conditions":"Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":120},{"nctId":"NCT06183242","phase":"PHASE2, PHASE3","title":"Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-05-27","conditions":"Cholestasis, Intrahepatic","enrollment":328},{"nctId":"NCT06183229","phase":"PHASE3","title":"Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-09-15","conditions":"Influenza, Acute Respiratory Infection","enrollment":166},{"nctId":"NCT06608641","phase":"PHASE3","title":"Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jina Pharmaceuticals Inc.","startDate":"2024-03-19","conditions":"Bipolar 1 Disorder","enrollment":490},{"nctId":"NCT06864182","phase":"PHASE1","title":"Relative Bioavailability Study of CX2101A for the Treatment of COVID-19","status":"COMPLETED","sponsor":"Heronova Pharmaceuticals","startDate":"2024-03-21","conditions":"COVID-19, Coronavirus Infection","enrollment":60},{"nctId":"NCT06860282","phase":"PHASE1","title":"A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects","status":"COMPLETED","sponsor":"Heronova Pharmaceuticals","startDate":"2022-12-26","conditions":"COVID-19, Coronavirus Pneumonia","enrollment":63},{"nctId":"NCT06827431","phase":"PHASE3","title":"The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","status":"NOT_YET_RECRUITING","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2025-02-14","conditions":"Major Depressive Disorder (MDD)","enrollment":770},{"nctId":"NCT04214990","phase":"PHASE3","title":"Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients","status":"RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2020-02-15","conditions":"Aspirin, Gastric Cancer","enrollment":1700},{"nctId":"NCT04315792","phase":"PHASE3","title":"Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients","status":"COMPLETED","sponsor":"Jina Pharmaceuticals Inc.","startDate":"2020-08-03","conditions":"Bipolar I Disorder","enrollment":124},{"nctId":"NCT06533878","phase":"PHASE1","title":"Evaluate Tolerability and Safety of HY209 in Healthy Volunteers","status":"ENROLLING_BY_INVITATION","sponsor":"Kukjeon Pharmaceutical Co.,Ltd.","startDate":"2023-09-13","conditions":"Dementia","enrollment":59},{"nctId":"NCT06337604","phase":"PHASE1","title":"The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets","status":"COMPLETED","sponsor":"TenNor Therapeutics Inc.","startDate":"2017-10-10","conditions":"Helicobacter Pylori Infection","enrollment":20},{"nctId":"NCT05879029","phase":"PHASE4","title":"Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2023-07-01","conditions":"Laryngopharyngeal Reflux","enrollment":72},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT04309721","phase":"PHASE3","title":"Perampanel in Focal Status Epilepticus","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-02","conditions":"Epilepticus; Status, Focal Motor","enrollment":1},{"nctId":"NCT02133521","phase":"PHASE2, PHASE3","title":"DLBS1033 for Acute Ischemic Stroke Patients","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-11-11","conditions":"Acute Ischemic Stroke, Partial Anterior Circulation Infarct, Lacunar Anterior Circulation Infarct","enrollment":80},{"nctId":"NCT02976701","phase":"PHASE2, PHASE3","title":"Effect of DLBS1033 After Primary PCI in Patients With STE-ACS","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2016-11","conditions":"ST Elevation Myocardial Infarction","enrollment":23},{"nctId":"NCT04672018","phase":"PHASE2","title":"Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis","status":"COMPLETED","sponsor":"University of Karachi","startDate":"2022-11-08","conditions":"Gastritis","enrollment":240},{"nctId":"NCT05762458","phase":"PHASE2","title":"The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","status":"UNKNOWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2023-02-28","conditions":"Major Depressive Disorder (MDD)","enrollment":240},{"nctId":"NCT03849664","phase":"PHASE3","title":"Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2017-06-02","conditions":"Cognitive Dysfunction","enrollment":200},{"nctId":"NCT02918006","phase":"PHASE2","title":"A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine","status":"COMPLETED","sponsor":"Vaxart","startDate":"2016-08-31","conditions":"Influenza","enrollment":179},{"nctId":"NCT05525156","phase":"PHASE2","title":"The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy","status":"SUSPENDED","sponsor":"Muhimbili University of Health and Allied Sciences","startDate":"2020-03-02","conditions":"Hiv, Cardiovascular Diseases","enrollment":454},{"nctId":"NCT04364997","phase":"PHASE3","title":"Study of Desvenlafaxine in Treating Major Depressive Disorder.","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2020-06-18","conditions":"Major Depressive Disorder","enrollment":420},{"nctId":"NCT05018013","phase":"PHASE2","title":"Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression","status":"UNKNOWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2021-08-21","conditions":"Major Depressive Disorder (MDD)","enrollment":240},{"nctId":"NCT03821883","phase":"NA","title":"Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2020-06-01","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":1120},{"nctId":"NCT01646437","phase":"PHASE3","title":"The International Polycap Study 3 (TIPS-3)","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2012-06","conditions":"Cardiovascular Disease, Fractures, Cancers","enrollment":7793},{"nctId":"NCT03708718","phase":"PHASE2","title":"Prednisolone in Early Diffuse Systemic Sclerosis","status":"COMPLETED","sponsor":"Prof. Ariane herrick","startDate":"2017-12-21","conditions":"Systemic Sclerosis","enrollment":35},{"nctId":"NCT04661709","phase":"PHASE4","title":"Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2021-03-01","conditions":"Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine","enrollment":502},{"nctId":"NCT02270242","phase":"PHASE4","title":"Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2015-07","conditions":"Cardiovascular Disease, Interventional Cardiology","enrollment":9006},{"nctId":"NCT02944448","phase":"PHASE2","title":"A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee","status":"COMPLETED","sponsor":"Cara Therapeutics, Inc.","startDate":"2016-09","conditions":"Osteoarthritis, Hip, Osteoarthritis, Knee, Arthritis","enrollment":761},{"nctId":"NCT04471922","phase":"PHASE1","title":"A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects","status":"COMPLETED","sponsor":"Sihuan Pharmaceutical Holdings Group Ltd.","startDate":"2019-03-21","conditions":"Healthy Volunteers","enrollment":45},{"nctId":"NCT04467060","phase":"PHASE1","title":"A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects","status":"COMPLETED","sponsor":"Sihuan Pharmaceutical Holdings Group Ltd.","startDate":"2014-08-14","conditions":"Healthy Male Volunteers","enrollment":74},{"nctId":"NCT04466748","phase":"PHASE1","title":"A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects","status":"COMPLETED","sponsor":"Sihuan Pharmaceutical Holdings Group Ltd.","startDate":"2015-09-08","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT03356769","phase":"PHASE2","title":"Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2017-11-20","conditions":"Tuberous Sclerosis Complex, Aspirin, Epilepsy","enrollment":98},{"nctId":"NCT02412852","phase":"PHASE2","title":"A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain","status":"COMPLETED","sponsor":"TheraVasc Inc.","startDate":"2015-04-28","conditions":"Diabetes","enrollment":26},{"nctId":"NCT03447821","phase":"PHASE2","title":"Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea","status":"COMPLETED","sponsor":"Cosmo Technologies Ltd","startDate":"2008-02","conditions":"Infectious Diarrhoea","enrollment":40},{"nctId":"NCT04034641","phase":"PHASE4","title":"Effect of Probiotics on Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2019-06-17","conditions":"Helicobacter Pylori Eradication","enrollment":238},{"nctId":"NCT04142151","phase":"NA","title":"Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2019-09-01","conditions":"Ischemic Stroke, Antiplatelet Effect","enrollment":60},{"nctId":"NCT03714672","phase":"PHASE3","title":"Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2017-08-26","conditions":"Acute Pain","enrollment":1151},{"nctId":"NCT03658187","phase":"NA","title":"Assessment of the Acute Effect of IP","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2018-07-19","conditions":"Deficiency Growth Hormone","enrollment":32},{"nctId":"NCT03850834","phase":"PHASE1","title":"Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subject","status":"UNKNOWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2019-03-10","conditions":"Depression","enrollment":36},{"nctId":"NCT03456388","phase":"PHASE1","title":"Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects","status":"COMPLETED","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2017-10-30","conditions":"Depression","enrollment":58},{"nctId":"NCT02930161","phase":"PHASE2","title":"Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome","status":"TERMINATED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2016-05-30","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":35},{"nctId":"NCT03787004","phase":"PHASE1","title":"A Placebo-Controlled, Two-Part Study, Oral Dose to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CNTX-6970 in Healthy Subjects","status":"COMPLETED","sponsor":"Centrexion Therapeutics","startDate":"2017-08-14","conditions":"Chronic Pain, Nociceptive Pain","enrollment":62},{"nctId":"NCT03037606","phase":"PHASE4","title":"Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets","status":"COMPLETED","sponsor":"Neutec Ar-Ge San ve Tic A.Ş","startDate":"2017-08-01","conditions":"Gastroesophageal Reflux Disease","enrollment":48},{"nctId":"NCT00743587","phase":"PHASE1","title":"A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Osteoarthritis Thumbs","enrollment":36},{"nctId":"NCT00501059","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-07-05","conditions":"Moderate Risk of CVD","enrollment":12546},{"nctId":"NCT02830932","phase":"PHASE1","title":"Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)","status":"COMPLETED","sponsor":"Vaxart","startDate":"2016-06-22","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":66},{"nctId":"NCT02868073","phase":"PHASE1","title":"Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine","status":"COMPLETED","sponsor":"Vaxart","startDate":"2016-07-29","conditions":"Norovirus Gastroenteritis","enrollment":66},{"nctId":"NCT02547792","phase":"PHASE1","title":"Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults","status":"COMPLETED","sponsor":"Vaxart","startDate":"2015-10-20","conditions":"Seasonal Influenza B","enrollment":54},{"nctId":"NCT00268996","phase":"PHASE2","title":"Integrated Biomarker And Imaging Study - 2","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-11-10","conditions":"Atherosclerosis","enrollment":336},{"nctId":"NCT01694537","phase":"PHASE2","title":"The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2012-07","conditions":"Healthy","enrollment":21},{"nctId":"NCT02362984","phase":"PHASE3","title":"DLBS1033 for the Treatment of Acute Ischemic Stroke","status":"TERMINATED","sponsor":"Dexa Medica Group","startDate":"2014-10","conditions":"Acute Ischemic Stroke","enrollment":9},{"nctId":"NCT03072082","phase":"PHASE4","title":"Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization","status":"UNKNOWN","sponsor":"Jun Li","startDate":"2017-06","conditions":"Coronary Artery Disease(CAD)","enrollment":440},{"nctId":"NCT03072121","phase":"PHASE4","title":"Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization","status":"UNKNOWN","sponsor":"Jun Li","startDate":"2017-06","conditions":"Coronary Artery Disease(CAD)","enrollment":440},{"nctId":"NCT02975076","phase":"NA","title":"Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2016-12","conditions":"Stroke, Acute, Ischemic Attack, Transient","enrollment":120},{"nctId":"NCT01762163","phase":"PHASE4","title":"Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2013-10","conditions":"Ischemic Stroke","enrollment":622},{"nctId":"NCT00234299","phase":"NA","title":"Effects of ASA on Prostate Tissue","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-12","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT02146664","phase":"PHASE2, PHASE3","title":"DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization","status":"WITHDRAWN","sponsor":"Dexa Medica Group","startDate":"2015-11","conditions":"Acute Non-ST Elevation Myocardial Infarction","enrollment":""},{"nctId":"NCT02008981","phase":"PHASE3","title":"Effect of Herbal Products on Platelet Function and Clotting","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2013-12","conditions":"Platelet Function Test","enrollment":75},{"nctId":"NCT01636271","phase":"","title":"SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-10","conditions":"Coronary Heart Disease","enrollment":28855},{"nctId":"NCT01513070","phase":"PHASE4","title":"A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis","status":"COMPLETED","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2012-04","conditions":"Coronary Artery Stenosis, Coronary Heart Disease","enrollment":120},{"nctId":"NCT00617526","phase":"PHASE2","title":"Naïve HIV POC Monotherapy Trial","status":"COMPLETED","sponsor":"Ardea Biosciences, Inc.","startDate":"2008-01","conditions":"HIV Infections","enrollment":48},{"nctId":"NCT00526097","phase":"PHASE3","title":"Dulcolax vs Placebo in Functional Constipation","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2007-09","conditions":"Constipation","enrollment":368},{"nctId":"NCT01526564","phase":"PHASE3","title":"Clinical Study on Acetyl-L-Carnitine","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2008-08","conditions":"Peripheral Sensory Neuropathy","enrollment":239},{"nctId":"NCT00400400","phase":"PHASE4","title":"Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-10","conditions":"Renal Transplantation","enrollment":400},{"nctId":"NCT01094483","phase":"PHASE1","title":"A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-03","conditions":"Platelet Inhibition","enrollment":40},{"nctId":"NCT00357968","phase":"PHASE2","title":"Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-08","conditions":"Coronary Artery Disease","enrollment":201},{"nctId":"NCT00236184","phase":"PHASE3","title":"E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2005-10","conditions":"Heartburn","enrollment":629}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["povidone, calcium stearate, hypromellose, polysorban, dyes"],"phase":"phase_3","status":"active","brandName":"Placebo enteric-coated tablet","genericName":"Placebo enteric-coated tablet","companyName":"POLYSAN Scientific & Technological Pharmaceutical Company","companyId":"polysan-scientific-technological-pharmaceutical-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo enteric-coated tablets are used in clinical trials to study various conditions, including osteoarthritis of the thumb, epilepsy, and coronary heart disease. The enteric coating is derived from the husks of the Indian plantain seed, also known as ispaghula husks.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}